S. Nakamura

发表

A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response

M. Kurosaki, N. Izumi, H. Marusawa, 2021, JGH open : an open access journal of gastroenterology and hepatology.

Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group

M. Kurosaki, N. Izumi, H. Marusawa, 2021, Journal of medical virology.

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

H. Harputluoglu, S. Yoon, H. Marusawa, 2023, The Lancet.

The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab

H. Shiraha, H. Hagihara, A. Takaki, 2023, Cancer medicine.

Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices

Y. Hiasa, A. Morishita, J. Tani, 2023, Journal of Gastroenterology.

Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

Y. Hiasa, A. Morishita, J. Tani, 2022, Oncology.

Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis

Y. Hiasa, A. Morishita, J. Tani, 2022, Cancer medicine.

Neutrophil–lymphocyte ratio predicts early outcomes in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: a multicenter analysis

Y. Hiasa, A. Morishita, J. Tani, 2022, European journal of gastroenterology & hepatology.

Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis

Y. Hiasa, T. Ishikawa, Shinichiro Nakamura, 2021, Oncology.

Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression

M. Kudo, Y. Hiasa, J. Tani, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

Application of radiofrequency ablation for the treatment of intermediate‐stage hepatocellular carcinoma

H. Shiraha, K. Kuwaki, A. Takaki, 2017, Journal of gastroenterology and hepatology.

A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

M. Tsuboi, M. Okada, H. Saji, 2010, Japanese journal of clinical oncology.

Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging‐determined proton density fat fraction

Shinichiro Nakamura, H. Toyoda, S. Yasuda, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Characteristics of hepatocellular carcinoma in patients with hepatitis C virus who received direct‐acting antiviral therapy and achieved sustained virological response: The impact of a hepatologist on surveillance

Shinichiro Nakamura, J. Tanaka, H. Iijima, 2022, JGH open : an open access journal of gastroenterology and hepatology.

The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma

K. Kuwaki, A. Takaki, Shinichiro Nakamura, 2017, Internal medicine.

Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study

M. Kudo, Y. Hiasa, J. Tani, 2021, Scientific Reports.

Use of non‐invasive serum glycan markers to distinguish non‐alcoholic steatohepatitis from simple steatosis

H. Shiraha, K. Kuwaki, A. Takaki, 2015, Journal of gastroenterology and hepatology.

Impact of first‐line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

Y. Hiasa, A. Morishita, J. Tani, 2023, Journal of gastroenterology and hepatology.

Prevention of biliary complication in radiofrequency ablation for hepatocellular carcinoma-Cooling effect by endoscopic nasobiliary drainage tube.

Shinichiro Nakamura, Yoshiyuki Kobayashi, Kazuhide Yamamoto, 2010, European journal of radiology.

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial.

Kenji Suzuki, M. Tsuboi, M. Okada, 2019, The Journal of thoracic and cardiovascular surgery.

Multilocular Pyogenic Liver Abscess with Poorly Liquefied Content: A Potential Therapeutic Concern

K. Morii, H. Okushin, Shinichiro Nakamura, 2017 .

Dementia with Lewy bodies: early diagnostic challenges

Shinichiro Nakamura, H. Fujishiro, E. Iseki, 2013, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G

I. Hyodo, K. Muro, Shinichiro Nakamura, 2021, Cancer medicine.

Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study.

N. Hattori, R. Kawamori, H. Watada, 2015, Journal of atherosclerosis and thrombosis.

Increased levels of tissue inhibitor of metalloproteinase‐1 in human hepatocellular carcinoma

Y. Shiratori, Shinichiro Nakamura, Yoshiyuki Kobayashi, 2004, Liver international : official journal of the International Association for the Study of the Liver.

Y. Nakanishi, H. Shiraha, Shin-ichi Nishina, 2012, International journal of cancer.

The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis

H. Shiraha, K. Kuwaki, H. Hagihara, 2013, Journal of Gastroenterology.

Genotype-phenotype correlation of Parkinson's disease with PRKN variants

G. Oyama, N. Hattori, T. Hatano, 2022, Neurobiology of Aging.

Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells

H. Shiraha, S. Horiguchi, M. Iwamuro, 2015, Oncology reports.

The formation of capsule and septum in human hepatocellular carcinoma

M. Uemura, Shinichiro Nakamura, Yoshiyuki Kobayashi, 2001, Virchows Archiv.

Sensitivity and Specificity of Des-Gamma-Carboxy Prothrombin for Diagnosis of Patients with Hepatocellular Carcinomas Varies According to Tumor Size

Yoichi M. Ito, Y. Ohashi, Y. Shiratori, 2006, The American Journal of Gastroenterology.

A case of primary intracranial hemangiopericytoma with hepatic metastases: successful treatment with radiofrequency ablation and transcatheter arterial chemoembolization

H. Shiraha, M. Iwamuro, Shinichiro Nakamura, 2009, Clinical journal of gastroenterology.

Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma

H. Shiraha, K. Kuwaki, H. Hagihara, 2011, International Journal of Clinical Oncology.

Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer

H. Shiraha, K. Kuwaki, H. Hagihara, 2013, Journal of Gastroenterology.

New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study

Y. Hiasa, A. Morishita, J. Tani, 2022, Cancer medicine.

Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings

M. Kudo, Y. Hiasa, A. Morishita, 2023, Oncology.

Prodromal dementia with Lewy bodies

Shinichiro Nakamura, H. Fujishiro, E. Iseki, 2015, Geriatrics & gerontology international.

Decreased expression of B7 costimulatory molecules and major histocompatibility complex class‐I in human hepatocellular carcinoma

I. Naito, Y. Shiratori, M. Uemura, 2004, Journal of gastroenterology and hepatology.

Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma

Y. Shiratori, M. Uemura, Shinichiro Nakamura, 2003, Journal of gastroenterology and hepatology.

Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma

H. Shiraha, K. Kuwaki, H. Hagihara, 2011, Journal of gastroenterology and hepatology.